A Litopenaeus vannamei elongation factor antimicrobial peptide BCE3 and its application
By using Litopenaeus vannamei extended factor antimicrobial peptide BCE3 to disrupt bacterial cell walls and bind to DNA, the safety issues of chemical preservatives and foodborne diseases caused by Bacillus cereus are resolved, achieving a natural antibacterial effect.
Patent Information
- Application Number
- CN202311024514.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-08-15
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-08-15
AI Technical Summary
In the existing technology, there are safety issues with chemical preservatives and frequent foodborne illnesses caused by Bacillus cereus, and there is a lack of effective natural alternatives.
A Litopenaeus vannamei elongation factor antimicrobial peptide BCE3 is provided, with the amino acid sequence GSFRYAWVLDKLK. It inhibits bacterial DNA synthesis by disrupting the bacterial cell wall, altering cell membrane permeability, and binding to bacterial genomic DNA.
It effectively inhibits and kills Bacillus cereus, and can be used in the preparation of antibacterial drugs, feed additives and food preservatives, with low risk of drug resistance and few side effects.
Smart Images

Figure CN117164669B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biotechnology, and in particular to a Litopenaeus vannamei elongation factor antimicrobial peptide BCE3 and its applications. Background Technology
[0002] Bacillus cereus ( Bacillus cereus Bacillus cereus is a pathogenic microorganism that can cause foodborne illnesses. Because it can form spores that are resistant to high temperatures and low humidity, it can be widely distributed in the environment and food. Bacillus cereus can produce two types of toxins that cause vomiting and diarrhea. Food poisoning associated with starchy foods such as rice and grains is usually caused by the vomiting toxin. This is because these foods are rich in carbohydrates, providing an ideal environment for the production of the vomiting toxin. In addition, improper storage of cooked rice and grains after cooking can also lead to Bacillus cereus contamination, resulting in frequent occurrences of Bacillus cereus food poisoning worldwide.
[0003] Currently, with the increasing severity of foodborne pathogen contamination, adding chemical preservatives, such as potassium sorbate and benzoic acid, is the most effective method. However, the safety of chemical preservatives is controversial, as they are considered carcinogenic, teratogenic, and have residual toxicity, leading consumers to often distrust chemical additives. Therefore, finding alternatives to chemical preservatives has become a major research focus. Antimicrobial peptides (AMPs) are a class of natural, small-molecule bioactive peptides with antibacterial or antifungal effects, also known as host defense peptides, produced by organisms such as bacteria, plants, vertebrates, and invertebrates. They possess rapid bactericidal action, low risk of drug resistance, and relatively few side effects, and are considered a potential alternative to chemical preservatives with promising application prospects.
[0004] In recent years, shrimp has become an important part of crustacean consumption. However, in shrimp processing, the focus is mainly on utilizing the shrimp meat, while the head, shell, and tail are often considered processing byproducts, despite containing a large amount of underutilized high-quality protein. Bacillus subtilis, a common Gram-positive bacterium, produces proteases during its growth that can degrade proteins in shrimp processing byproducts to produce bioactive peptides. Studies have reported that some of these bioactive peptides exhibit antibacterial activity. Therefore, through appropriate technologies and biotransformation processes, shrimp processing byproducts can be converted into valuable products rich in bioactive peptides.
[0005] Therefore, this study discovered a novel antimicrobial peptide, BCE3, by fermenting shrimp heads with Bacillus subtilis. BCE3 exhibited strong antimicrobial activity against Bacillus cereus, and its antimicrobial mechanism was further explored, providing a theoretical basis for the prevention and control of foodborne pathogenic microorganisms. Summary of the Invention
[0006] The purpose of this invention is to overcome the shortcomings of the prior art and provide an antimicrobial peptide BCE3 for Litopenaeus vannamei and its application, thereby solving the problems mentioned in the background art.
[0007] One of the technical solutions adopted by this invention to solve its technical problem is to provide a Litopenaeus vannamei elongation factor antimicrobial peptide BCE3. Its amino acid sequence is GSFRYAWVLDKLK, as shown in SEQ ID NO: 1.
[0008] The antimicrobial peptide has a molecular weight of 1582.9 Daltons, a positive charge of +2, and a total hydrophobicity of 46%.
[0009] The second technical solution adopted by the present invention to solve its technical problem is: to provide the application of Litopenaeus vannamei extended factor antimicrobial peptide BCE3 in the preparation of antimicrobial drugs, which are used to inhibit and / or kill Bacillus cereus.
[0010] The third technical solution adopted by the present invention to solve its technical problem is: to provide an antibacterial drug, the effective ingredient of which includes Litopenaeus vannamei extended factor antimicrobial peptide BCE3, wherein the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO: 1.
[0011] In a preferred embodiment of the present invention, the active ingredient of the antibacterial drug is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO: 1.
[0012] In a preferred embodiment of the present invention, the antibacterial drug is used to inhibit and / or kill Bacillus cereus.
[0013] The fourth technical solution adopted by the present invention to solve its technical problem is: to provide a feed additive whose effective ingredient includes Litopenaeus vannamei extended factor antimicrobial peptide BCE3, wherein the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO: 1.
[0014] In a preferred embodiment of the present invention, the effective ingredient of the feed additive is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO: 1.
[0015] In a preferred embodiment of the present invention, the feed additive is used to inhibit and / or kill Bacillus cereus.
[0016] The fifth technical solution adopted by the present invention to solve its technical problem is: to provide a food preservative, the effective ingredient of which is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO: 1.
[0017] In a preferred embodiment of the present invention, the food preservative is used to inhibit and / or kill Bacillus cereus.
[0018] This invention investigates the antimicrobial activity of the antimicrobial peptide BCE3 against Bacillus cereus using MBC and Time-kill assays. The effects of BCE3 on the bacterial cell wall are observed by detecting changes in alkaline phosphatase activity, and the degree of damage to the bacterial cell membrane by propidium iodide staining is observed. Simultaneously, genomic DNA of Bacillus cereus is extracted to verify its effect on bacterial DNA. Experimental results show that this peptide has a significant inhibitory effect on Bacillus cereus. The antimicrobial peptide of this invention is a cationic antimicrobial peptide that exerts its antimicrobial effect by disrupting the bacterial cell wall, altering cell membrane permeability, penetrating the cell membrane, and binding to bacterial genomic DNA, thereby inhibiting bacterial DNA synthesis.
[0019] The antimicrobial peptide BCE3 will damage bacteria through the following mechanisms: it can disrupt the bacterial cell wall, alter the permeability of the bacterial cell membrane, penetrate the cell membrane, bind to the bacterial genomic DNA, inhibit bacterial DNA synthesis, and thus lead to bacterial death.
[0020] The antimicrobial peptides of the present invention can be synthesized using methods known to those skilled in the art, such as solid-phase synthesis, and purified using methods known to those skilled in the art, such as high-performance liquid chromatography.
[0021] Implementing this invention has the following beneficial effects: This invention focuses on the elongation factor of Litopenaeus vannamei and, through screening, discovered a novel antimicrobial peptide, BCE3, with a novel amino acid sequence. The antimicrobial activity of BCE3 against Bacillus cereus was investigated. Experimental results show that this peptide has a strong inhibitory effect on Bacillus cereus. Its antimicrobial mechanism involves first disrupting the bacterial cell wall and altering cell membrane permeability, then binding to bacterial genomic DNA, inhibiting bacterial DNA synthesis, thereby leading to bacterial death. The antimicrobial peptide BCE3 of this invention can be used to prepare drugs, feed additives, or food preservatives for the prevention or inhibition of Bacillus cereus infection. Attached Figure Description
[0022] Figure 1 This is a structural view of the predicted model for the antimicrobial peptide BCE3 of this invention.
[0023] Figure 2 This is a comparison chart showing the determination of the minimum bactericidal concentration (MBC) of the antimicrobial peptide BCE3 of this invention against Bacillus cereus.
[0024] The AF antimicrobial peptide BCE3 concentrations were 0 μg / mL, 500 μg / mL, 250 μg / mL, 125 μg / mL, 62.5 μg / mL, and 31.3 μg / mL, respectively.
[0025] Figure 3 The time-kill curve of the antimicrobial peptide BCE3 of the present invention against Bacillus cereus is shown, where 1 / 2×MBC, 1×MBC, and 2×MBC are 62.5 μg / mL, 125 μg / mL, and 250 μg / mL, respectively.
[0026] Figure 4 This is a diagram showing the effect of the antimicrobial peptide BCE3 of the present invention on the cell wall of Bacillus cereus (alkaline phosphatase leakage).
[0027] Figure 5 Figure showing the effect of the antimicrobial peptide BCE3 on the cell membrane permeability of Bacillus cereus by propidium iodide staining.
[0028] Figure 6 This diagram illustrates the effect of the antimicrobial peptide BCE3 of this invention on the cell membrane permeability of Bacillus cereus (nucleic acid leakage).
[0029] Figure 7 This diagram illustrates the effect of the antimicrobial peptide BCE3 of this invention on the cell membrane permeability of Bacillus cereus (protein leakage).
[0030] Figure 8 This image shows the effect of antimicrobial peptide BCE3 on the cell membrane permeability of Bacillus cereus analyzed using fluorescence microscopy. In the image, a is the bright field image of the control group, b is the fluorescence image of the PI channel in the control group, c is a combined image of a and b, d is the bright field image of the antimicrobial peptide BCE3 treatment, e is the fluorescence image of the PI channel in the antimicrobial peptide BCE3 treatment, and f is a combined image of d and e.
[0031] Figure 9 Figure showing the effect of the antimicrobial peptide BCE3 on apoptosis in Bacillus cereus cells analyzed by flow cytometry.
[0032] Figure 10 This is an electrophoresis diagram showing the binding of the antimicrobial peptide BCE3 of this invention to the genomic DNA of Bacillus cereus.
[0033] Among them, band 7: blank control; Bands 6-1 represent antimicrobial peptide BCE3 with DNA mass ratios of 10 / 10, 10 / 8, 10 / 6, 10 / 4, 10 / 2, and 10 / 1, respectively.
[0034] Figure 11 This is a fluorescence spectrum of the antimicrobial peptide BCE3 of the present invention competitively binding to the genomic DNA of Bacillus cereus.
[0035] Figure 12 This is a graph showing the concentration of the antimicrobial peptide BCE3 of the present invention in rice storage as a Bacillus cereus strain. 1×MBC and 2×MBC represent the concentrations of added antimicrobial peptide BCE3 as 125 μg / mL and 250 μg / mL, respectively. The blank control group was prepared by replacing the antimicrobial peptide BCE3 with an equal volume of sterile PBS. Detailed Implementation
[0036] To better understand the present invention, the present invention will be further described in detail below with reference to the embodiments and accompanying drawings. However, those skilled in the art will understand that the following embodiments are not intended to limit the scope of protection of the present invention, and any changes and variations made on the basis of the present invention are within the scope of protection of the present invention.
[0037] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0038] Unless otherwise specified, all materials and reagents used in the following examples are commercially available.
[0039] Example 1: Screening of BCE3, an antimicrobial peptide extended by Litopenaeus vannamei First, samples were prepared by fermenting the homogenate of Litopenaeus vannamei heads using Bacillus subtilis. Fresh Litopenaeus vannamei head homogenate was fermented in liquid form at 37 ℃ and 160 r / min using Bacillus subtilis as the fermenting agent. After fermentation, the supernatant was collected after centrifugation at 3000 r / min for 5 min and filtered through a 3000 Da filter membrane. The sample was then stored at -20 ℃ for further analysis.
[0040] Chromatographic conditions: Injection volume: 5.0 μL Chromatographic column: C18 analytical column, 25 cm in length and 75 μm in inner diameter. Mobile phase: A: 0.1% methanol aqueous solution; B: acetonitrile The obtained peptide mass spectra were differentiated and identified using the search software MAXQUANT v1.6.5.0 and the database uniprot shrimp protein library. Then, the sequences were screened using the APD3 online server, and the peptide structures were predicted using the Swiss-model server. Finally, an antimicrobial peptide with strong antibacterial activity against Bacillus cereus was obtained, with the sequence GSFRYAWVLDKLK, named BCE3, and a molecular weight of 1582.9 Da. It was chemically synthesized (by Beijing Zhongke Yaguang Biotechnology Co., Ltd.) and its antibacterial activity was verified.
[0041] Example 2: 3D structure prediction of antimicrobial peptide BCE3 The structure of the antimicrobial peptide BCE3 was predicted using the online structure prediction server Swiss-model, and then edited and modified using Pymol software to obtain the secondary structure of the antimicrobial peptide BCE3, such as... Figure 1 As shown.
[0042] Example 3: Determination of the minimum bactericidal concentration (MBC) of antimicrobial peptide BCE3 Bacillus cereus was cultured at 37 °C to the logarithmic growth phase and then diluted to a final concentration of 10 μL in 0.01 M pH 7.2 phosphate buffer. 5 CFU / mL. The antimicrobial peptide BCE3 was dissolved in phosphate buffer and incubated with an equal volume of bacteria at 37 °C for 2 h. The minimum bactericidal concentration (MBC) is the concentration of the antimicrobial peptide that can kill bacteria after incubation at 37 °C. For example... Figure 2 As shown, the minimum bactericidal concentration (MBC) of the antimicrobial peptide BCE3 against Bacillus cereus is 125 μg / mL.
[0043] Example 4: Time-kill curve determination of antimicrobial peptide BCE3 The time-kill curve of the antimicrobial peptide BCE3 was determined using the plate count method. Bacillus cereus was cultured at 37 °C to the logarithmic growth phase and diluted to 10⁻¹⁰ in 0.01 M pH 7.2 phosphate buffer. 5 CFU / mL. Peptides at concentrations of 1 / 2×MBC, 1×MBC, and 2×MBC were mixed with equal volumes of bacterial suspension and incubated at 37 ℃ in a biochemical incubator. At different time points (0.5, 1, 1.5, 2, 2.5, and 3 h), 0.02 mL of bacterial suspension was obtained and incubated on nutrient broth plates at 37 ℃ for 24 h before colony counting. Results are as follows: Figure 3 As shown, the antimicrobial peptide BCE3 of 1×MBC can kill Bacillus cereus within 3 hours.
[0044] Example 5: Effects of antimicrobial peptide BCE3 on bacterial cell walls Bacillus cereus was cultured at 37 °C to the logarithmic growth phase. A certain amount of bacterial suspension was taken and washed three times with 0.01 M pH 7.2 phosphate buffer, and the bacterial concentration was adjusted to 10. 8 CFU / mL. Mix with an equal volume of antimicrobial peptide BCE3 to final concentrations of 1 / 2×MBC, 1×MBC, and 2×MBC. Use an equal volume of phosphate buffer and bacterial suspension as a blank control. Incubate at 37 ℃ for 2 h, then remove the bacterial suspension and centrifuge at 3500 rpm for 10 min to obtain the supernatant. According to the alkaline phosphatase (AKP) kit instructions, at OD... 510Under the specified conditions, the AKP enzyme activity in each supernatant was measured using a 96-well plate and a microplate reader. The changes in AKP enzyme activity were ultimately used to reflect the effect of the peptide on the bacterial cell wall. Results are as follows: Figure 4 As shown, alkaline phosphatase (AKP) is an intracellular enzyme located between the cell wall and cell membrane. When the cell wall is damaged, it leaks out of the bacteria and enters the extracellular environment. Therefore, the extent of cell wall damage caused by antimicrobial peptides can be determined by detecting AKP activity. The AKP activity of Bacillus cereus increased after treatment with the antimicrobial peptide BCE3, and the increase was dose-dependent.
[0045] Example 6: Effect of antimicrobial peptide BCE3 on bacterial cell membrane permeability The effect of the antimicrobial peptide BCE3 on bacterial cell membrane permeability was analyzed using propidium iodide (PI) staining. Bacillus cereus was inoculated into LB broth and cultured at 37 °C and 200 r / min until it reached the logarithmic growth phase. A certain amount of bacterial culture in the logarithmic growth phase was collected, centrifuged, and the supernatant was discarded. The collected bacterial cells were washed three times with 0.01 M pH 7.2 phosphate buffer, and the bacterial concentration was adjusted to 10. 5-6 CFU / mL. Peptides were dissolved in phosphate buffer to concentrations of 1 / 2×MBC, 1×MBC, and 2×MBC. The blank control group was replaced with phosphate buffer. Incubation was performed at 37 °C with equal volumes of bacteria for 2 h. After incubation, 100 μL was centrifuged, the supernatant was discarded, and 100 μL of PI dye (30 μM) was added. The mixture was vortexed at 25 °C and incubated at 4 °C in the dark for 15 min. After staining, the sample was washed twice with 0.1 M PBS and resuspended in 100 μL. The fluorescence spectrum of the sample in the excitation wavelength range of 535 nm and the emission wavelength range of 570-750 nm was measured using a multi-functional microplate reader. PI is a nucleic acid dye with the strongest fluorescence absorption at an excitation wavelength of 535 nm and an emission wavelength of 615 nm. It cannot cross the normal cell membrane, but when the cell membrane is damaged or ruptured, PI can enter the cell membrane and bind to DNA, displaying red fluorescence. The degree of cell damage can be determined based on the fluorescence intensity. The binding of PI to bacterial genomic DNA treated with different concentrations of antimicrobial peptides is as follows: Figure 5 As shown, the fluorescence intensity of Bacillus cereus treated with different concentrations of antimicrobial peptide BCE3 was higher than that of the blank control group, indicating that treatment with antimicrobial peptide BCE3 damaged the bacterial cell membrane and increased its permeability. The fluorescence intensity of the sample treated with 2×MBC of antimicrobial peptide BCE3 was greater than that of the sample treated with 1 / 2×MBC of antimicrobial peptide, indicating that high doses of antimicrobial peptide BCE3 increased the permeability of the bacterial cell membrane, leading to more PI entering the cell, binding to DNA, and emitting fluorescence.
[0046] Example 7: Effect of antimicrobial peptide BCE3 on bacterial cell membrane permeability (nucleic acid and protein leakage) Bacterial cell membrane integrity is assessed by measuring the leakage of intracellular proteins. *Bacillus cereus* was inoculated into LB broth and cultured at 37 °C and 200 r / min until the logarithmic growth phase. A certain amount of bacterial culture in the logarithmic phase was collected, centrifuged, and the supernatant was discarded. The collected bacterial cells were washed three times with 0.01M pH 7.2 phosphate buffer, and the bacterial concentration was adjusted to 10. 8 CFU / mL. Peptides were dissolved in phosphate buffer to final concentrations of 1 / 2×MBC, 1×MBC, and 2×MBC. The blank control group was replaced with phosphate buffer, and an equal volume was mixed with bacteria. The positive control group was replaced with nisin (900 IU / mg; Maclean's, Shanghai, China). After thorough mixing, the mixture was incubated at 37 ℃ for a specified time. Samples were taken at 0 min, 60 min, 120 min, and 180 min of culture, centrifuged at 10000 r / min for 2 min, and the supernatant was measured at 260 nm and 280 nm to detect intracellular nucleic acid and protein leakage, respectively. Results Figures 6-7 As shown. Under normal conditions, nucleic acids and proteins in the culture medium remain relatively stable at low levels. However, after treatment with the antimicrobial peptide BCE3 for 180 min, the leakage of both nucleic acids and proteins in the bacterial culture increased. Furthermore, the leakage of nucleic acids and proteins in the bacterial culture after treatment with 1×MBC (125 μg / mL) of the antimicrobial peptide BCE3 was equivalent to that after treatment with 500 μg / mL of nisin.
[0047] Example 8: Fluorescence microscopy analysis of the effect of antimicrobial peptide BCE3 on cell permeability Take a certain amount of bacterial culture in the logarithmic growth phase, centrifuge and discard the supernatant. Wash the collected bacterial cells three times with sterile 0.01 M pH 7.2 phosphate buffer and adjust the bacterial concentration to 1×10⁻⁶. 6 CFU / mL. Antimicrobial peptide BCE3 was added to the bacterial culture to a final concentration of 1×MBC, and incubated at 37 ℃ for 2 h. The blank control group was replaced with an equal volume of PBS. After incubation, 100 μL of the mixture was added to an equal volume of PI dye, vortexed at 25 ℃, and incubated at 4 ℃ in the dark for 15 min. After staining, the solution was washed twice with sterile PBS and resuspended in 100 μL. After slide preparation, images were captured using a fluorescence microscope, selecting the PI channel. Results are as follows: Figure 8As shown, in the PBS-treated control group, most cells did not emit red fluorescence, with only a small amount of weak red fluorescence, presumably due to normal bacterial cell death. After treatment with the antimicrobial peptide BCE3 at a concentration of 1×MBC, the Bacillus cereus cell membrane was damaged, and most cells emitted red fluorescence after being contaminated with PI. This result indicates that the antimicrobial peptide BCE3 at a concentration of 1×MBC disrupts the integrity of the bacterial cell membrane, providing numerical evidence for the fluorescence intensity of PI.
[0048] Example 9: Effect of antimicrobial peptide BCE3 on apoptosis The effect of the antimicrobial peptide BCE3 on apoptosis in Bacillus cereus was analyzed by flow cytometry. Bacterial suspensions activated to the logarithmic growth phase were adjusted to a concentration of 1 × 10⁻⁶. 5-6 CFU / mL. The cells were treated with the antimicrobial peptide BCE3 at concentrations of 1×MBC and 2×MBC for 1 h, 2 h, and 3 h, respectively, at 37 ℃. A negative control was prepared by mixing an equal volume of sterile 0.01 M PBS (pH 7.2) with the bacterial suspension, and a positive control was prepared by mixing an equal volume of nisin with the bacterial suspension. After incubation, the cells were processed according to the Annexin V-FITC / PI apoptosis kit instructions, and analyzed using a flow cytometer equipped with CytExpert software. Results are as follows: Figure 9 As shown in the figure, cells in the LL region are normal viable cells. After 3 hours of treatment with the antimicrobial peptide BCE3 at 2×MBC concentrations, the viable cell rate of Bacillus cereus was 6.99%, lower than that of the positive control group (67.04%). When treating Bacillus cereus with different concentrations of antimicrobial peptide BCE3, the viable cell rate decreased with increasing concentration and treatment time, and the viable cell rate after treatment with antimicrobial peptide BCE3 was consistently lower than that of the positive control. These results indicate that antimicrobial peptide BCE3 has a strong antibacterial effect on Bacillus cereus, and its antibacterial effect is time- and concentration-dependent, and its antibacterial effect is superior to that of nisin.
[0049] Example 10: Interaction between antimicrobial peptide BCE3 and bacterial DNA The interaction between the antimicrobial peptide BCE3 and the genomic DNA of Bacillus cereus was investigated using the DNA gel retardation method. Bacteria were cultured in 50 mL of nutrient broth (NB) at 37 °C for 12 h, and bacterial genomic DNA was extracted using a bacterial genomic DNA extraction kit. The interaction was studied at an optical density ratio of 1.70 ≤ OD at 260 nm and 280 nm. 260 / OD 280The purity of the extracted genomic DNA was evaluated by a concentration ≤ 1.90. Next, Bacillus cereus DNA (161 ng / μL) was mixed with a continuous amount of the antimicrobial peptide BCE3 at 25°C for 90 min, and the mixture was electrophoresed on a 1.5% agarose gel. Gel retardation was observed under UV irradiation using a gel imaging system (QuickGel6200, Mona, Suzhou, China). Figure 10 As shown, the agarose gel retardation assay can analyze the binding of antimicrobial peptides to bacterial DNA by analyzing the electrophoretic migration of the samples. If the antimicrobial peptide BCE3 binds to the DNA of Bacillus cereus, its migration rate in electrophoresis will be affected, i.e., it will lag behind the migration distance of DNA alone. In band 6-1, retardation occurs when the mass ratio of antimicrobial peptide BCE3 to DNA is 10 / 10. As the concentration of antimicrobial peptide increases, it can be observed that all DNA is trapped near the well. At the same time, the DNA band darkens significantly, which may be because the binding of antimicrobial peptide BCE3 to DNA competes with the binding sites of nucleic acid dyes to DNA, thus darkening the DNA band.
[0050] Example 11: Fluorescence spectroscopy experiment on the competitive binding of antimicrobial peptide BCE3 to DNA by EB Fluorescence spectroscopy analysis of the competitive binding of antimicrobial peptide BCE3 to DNA with ethidium bromide (EB) to analyze the interaction mechanism of antimicrobial peptide BCE3 with bacterial genomic DNA: Bacillus cereus genomic DNA was diluted to 50 μg / mL with TE buffer. The reaction was performed in 96-well plates. First, 5 μL of DNA solution and 10 μL of 100 μg / mL EB solution were added to each well, mixed, and incubated at 37 °C in the dark for 10 min. Then, 50 μL of peptide solutions of different concentrations were added, with 50 μL of sterile distilled water used as a blank control group. After mixing, the plates were incubated at 37 °C in the dark for 30 min. After incubation, the fluorescence spectra of the samples were measured using a multi-mode microplate reader in the excitation wavelength range of 535 nm and the emission wavelength range of 550-750 nm. In aqueous solution, EB fluorescence was weak, but its fluorescence intensity increased significantly when it bound to double-stranded DNA with high affinity and intercalation. If a substance in the EB-DNA complex system that can interact similarly with DNA competes with EB bound to DNA, the fluorescence intensity of the system will decrease, indicating that the competitor binds to DNA through an intercalation mechanism similar to EB. Therefore, by measuring the change in the fluorescence spectrum of the DNA-EB complex system interacting with the competitor, we can determine whether the competitor also binds to DNA through an intercalation mechanism, just like EB. Figure 11It can be seen that as the concentration of antimicrobial peptide BCE3 increases, the fluorescence intensity of the EB-DNA complex decreases, indicating that the antimicrobial peptide BCE3 intercalates with Bacillus cereus DNA, competing with the EB that was previously bound to the DNA base pairs, and replacing the EB to bind to the DNA in an intercalating manner, thus reducing the fluorescence intensity of the entire system.
[0051] Example 12: Application of antimicrobial peptide BCE3 in rice Bacillus cereus was cultured in LB medium at 37 °C until the logarithmic growth phase, washed three times with PBS, and resuspended to 1 × 10⁻⁶. 3-4 CFU / mL, 1 mL of bacterial culture was added to sterilized rice for artificial contamination, and equal amounts of antimicrobial peptide BCE3 (1×MBC, 2×MBC) were added to treat the samples. The blank control group was treated with an equal amount of sterile PBS instead of antimicrobial peptide BCE3. Samples were placed at 25 ℃ and collected at 2 h, 4 h, 6 h, and 8 h. The determination of total bacterial count in food microbiology was performed according to the national standard GB 4789.2-2022. The results are as follows. Figure 12 As shown, the initial bacterial concentration was 2.5 log CFU / mL. The number of Bacillus cereus in the blank control group increased to 4.8 log CFU / mL during the experiment. However, after treatment with antimicrobial peptide BCE3 at concentrations of 1×MBC and 2×MBC, the number of Bacillus cereus decreased to 2.0 log CFU / mL and 1.1 log CFU / mL, respectively, indicating that antimicrobial peptide BCE3 can effectively inhibit the growth of Bacillus cereus in rice.
[0052] In summary, this invention provides a novel antimicrobial peptide, BCE3, with a minimum bactericidal concentration (MBC) of 125 μg / mL against Bacillus cereus, indicating that BCE3 has a strong inhibitory effect on this bacillus. The antimicrobial peptide BCE3 of this invention first disrupts the bacterial cell wall, penetrates the bacterial cell membrane, alters cell membrane permeability, and then binds to bacterial genomic DNA, inhibiting bacterial DNA synthesis, thereby leading to bacterial death.
[0053] While specific embodiments of the present invention have been described above, those skilled in the art should understand that the specific embodiments described are merely illustrative and not intended to limit the scope of the present invention. Equivalent modifications and variations made by those skilled in the art in accordance with the spirit of the present invention should be covered within the scope of protection of the claims of the present invention.
Claims
1. A Litopenaeus vannamei elongation factor antimicrobial peptide BCE3, the amino acid sequence of which is shown in SEQ ID NO:
1.
2. The application of the Litopenaeus vannamei extended factor antimicrobial peptide BCE3 as described in claim 1 in the preparation of antimicrobial drugs, characterized in that: The antibacterial drug is used to inhibit and / or kill Bacillus cereus.
3. An antibacterial drug, characterized in that: Its active ingredient is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO:
1.
4. An antibacterial drug as described in claim 3, characterized in that: The antibacterial drug is used to inhibit and / or kill Bacillus cereus.
5. A feed additive, characterized in that: Its active ingredient is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO:
1.
6. The feed additive as described in claim 5, characterized in that: The feed additive is used to inhibit and / or kill Bacillus cereus.
7. A food preservative, characterized in that: Its active ingredient is Litopenaeus vannamei extended factor antimicrobial peptide BCE3, and the amino acid sequence of the antimicrobial peptide BCE3 is SEQ ID NO:
1.
8. A food preservative as described in claim 7, characterized in that: The food preservative is used to inhibit and / or kill Bacillus cereus.
